Shopping Cart 0
Cart Subtotal
AED 0

Global Gene Therapy in Oncology Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 17910

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 26864

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 35819

Details

Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient.

Scope of the Report:

The global Gene Therapy in Oncology market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gene Therapy in Oncology.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Gene Therapy in Oncology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gene Therapy in Oncology market by product type and applications/end industries.

Market Segment by Companies, this report covers

Bristol-Myers Squibb

Cold Genesys

Advantagene

Amgen

AstraZeneca

Bio-Path Holdings

CRISPR Therapeutics

Editas Medicine

Geron Corp

Idera Pharmaceuticals

Intellia Therapeutics

Johnson & Johnson

Marsala Biotech

Merck

Mologen AG

Oncolytics Biotech

Oncosec

Oncotelic

Shenzhen SiBiono GeneTech

Sillajen Biotherapeutics

Tocagen

UniQure

Ziopharm Oncology

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Ex Vivo

In Vivo

Market Segment by Applications, can be divided into

Hospitals

Diagnostics Centers

Research Institutes

READ MORE

Table Of Content

Scope

Table of Contents

1 Gene Therapy in Oncology Market Overview

1.1 Product Overview and Scope of Gene Therapy in Oncology

1.2 Classification of Gene Therapy in Oncology by Types

1.2.1 Global Gene Therapy in Oncology Revenue Comparison by Types (2019-2024)

1.2.2 Global Gene Therapy in Oncology Revenue Market Share by Types in 2018

1.2.3 Ex Vivo

1.2.4 In Vivo

1.3 Global Gene Therapy in Oncology Market by Application

1.3.1 Global Gene Therapy in Oncology Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Hospitals

1.3.3 Diagnostics Centers

1.3.4 Research Institutes

1.4 Global Gene Therapy in Oncology Market by Regions

1.4.1 Global Gene Therapy in Oncology Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Gene Therapy in Oncology Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Gene Therapy in Oncology Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gene Therapy in Oncology Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Gene Therapy in Oncology Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gene Therapy in Oncology Status and Prospect (2014-2024)

1.5 Global Market Size of Gene Therapy in Oncology (2014-2024)

2 Manufacturers Profiles

2.1 Bristol-Myers Squibb

2.1.1 Business Overview

2.1.2 Gene Therapy in Oncology Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.2 Cold Genesys

2.2.1 Business Overview

2.2.2 Gene Therapy in Oncology Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Cold Genesys Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.3 Advantagene

2.3.1 Business Overview

2.3.2 Gene Therapy in Oncology Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Advantagene Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.4 Amgen

2.4.1 Business Overview

2.4.2 Gene Therapy in Oncology Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Amgen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.5 AstraZeneca

2.5.1 Business Overview

2.5.2 Gene Therapy in Oncology Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 AstraZeneca Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.6 Bio-Path Holdings

2.6.1 Business Overview

2.6.2 Gene Therapy in Oncology Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Bio-Path Holdings Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.7 CRISPR Therapeutics

2.7.1 Business Overview

2.7.2 Gene Therapy in Oncology Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 CRISPR Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.8 Editas Medicine

2.8.1 Business Overview

2.8.2 Gene Therapy in Oncology Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Editas Medicine Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.9 Geron Corp

2.9.1 Business Overview

2.9.2 Gene Therapy in Oncology Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Geron Corp Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.10 Idera Pharmaceuticals

2.10.1 Business Overview

2.10.2 Gene Therapy in Oncology Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.11 Intellia Therapeutics

2.11.1 Business Overview

2.11.2 Gene Therapy in Oncology Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Intellia Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.12 Johnson & Johnson

2.12.1 Business Overview

2.12.2 Gene Therapy in Oncology Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Johnson & Johnson Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.13 Marsala Biotech

2.13.1 Business Overview

2.13.2 Gene Therapy in Oncology Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Marsala Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.14 Merck

2.14.1 Business Overview

2.14.2 Gene Therapy in Oncology Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Merck Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.15 Mologen AG

2.15.1 Business Overview

2.15.2 Gene Therapy in Oncology Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Mologen AG Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.16 Oncolytics Biotech

2.16.1 Business Overview

2.16.2 Gene Therapy in Oncology Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Oncolytics Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.17 Oncosec

2.17.1 Business Overview

2.17.2 Gene Therapy in Oncology Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Oncosec Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.18 Oncotelic

2.18.1 Business Overview

2.18.2 Gene Therapy in Oncology Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 Oncotelic Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.19 Shenzhen SiBiono GeneTech

2.19.1 Business Overview

2.19.2 Gene Therapy in Oncology Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.20 Sillajen Biotherapeutics

2.20.1 Business Overview

2.20.2 Gene Therapy in Oncology Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 Sillajen Biotherapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.21 Tocagen

2.21.1 Business Overview

2.2.2 Gene Therapy in Oncology Type and Applications

2.21.2.1 Product A

2.21.2.2 Product B

2.21.3 Tocagen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.22 UniQure

2.22.1 Business Overview

2.22.2 Gene Therapy in Oncology Type and Applications

2.22.2.1 Product A

2.22.2.2 Product B

2.22.3 UniQure Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.23 Ziopharm Oncology

2.23.1 Business Overview

2.23.2 Gene Therapy in Oncology Type and Applications

2.23.2.1 Product A

2.23.2.2 Product B

2.23.3 Ziopharm Oncology Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

3 Global Gene Therapy in Oncology Market Competition, by Players

3.1 Global Gene Therapy in Oncology Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Gene Therapy in Oncology Players Market Share

3.2.2 Top 10 Gene Therapy in Oncology Players Market Share

3.3 Market Competition Trend

4 Global Gene Therapy in Oncology Market Size by Regions

4.1 Global Gene Therapy in Oncology Revenue and Market Share by Regions

4.2 North America Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

4.3 Europe Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

4.5 South America Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

5 North America Gene Therapy in Oncology Revenue by Countries

5.1 North America Gene Therapy in Oncology Revenue by Countries (2014-2019)

5.2 USA Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

5.3 Canada Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

5.4 Mexico Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

6 Europe Gene Therapy in Oncology Revenue by Countries

6.1 Europe Gene Therapy in Oncology Revenue by Countries (2014-2019)

6.2 Germany Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

6.3 UK Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

6.4 France Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

6.5 Russia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

6.6 Italy Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Gene Therapy in Oncology Revenue by Countries

7.1 Asia-Pacific Gene Therapy in Oncology Revenue by Countries (2014-2019)

7.2 China Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

7.3 Japan Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

7.4 Korea Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

7.5 India Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

8 South America Gene Therapy in Oncology Revenue by Countries

8.1 South America Gene Therapy in Oncology Revenue by Countries (2014-2019)

8.2 Brazil Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

8.3 Argentina Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

8.4 Colombia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Gene Therapy in Oncology by Countries

9.1 Middle East and Africa Gene Therapy in Oncology Revenue by Countries (2014-2019)

9.2 Saudi Arabia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

9.3 UAE Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

9.4 Egypt Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

9.5 Nigeria Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

9.6 South Africa Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

10 Global Gene Therapy in Oncology Market Segment by Type

10.1 Global Gene Therapy in Oncology Revenue and Market Share by Type (2014-2019)

10.2 Global Gene Therapy in Oncology Market Forecast by Type (2019-2024)

10.3 Ex Vivo Revenue Growth Rate (2014-2024)

10.4 In Vivo Revenue Growth Rate (2014-2024)

11 Global Gene Therapy in Oncology Market Segment by Application

11.1 Global Gene Therapy in Oncology Revenue Market Share by Application (2014-2019)

11.2 Gene Therapy in Oncology Market Forecast by Application (2019-2024)

11.3 Hospitals Revenue Growth (2014-2019)

11.4 Diagnostics Centers Revenue Growth (2014-2019)

11.5 Research Institutes Revenue Growth (2014-2019)

12 Global Gene Therapy in Oncology Market Size Forecast (2019-2024)

12.1 Global Gene Therapy in Oncology Market Size Forecast (2019-2024)

12.2 Global Gene Therapy in Oncology Market Forecast by Regions (2019-2024)

12.3 North America Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

12.4 Europe Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

12.6 South America Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Gene Therapy in Oncology Picture

Table Product Specifications of Gene Therapy in Oncology

Table Global Gene Therapy in Oncology and Revenue (Million USD) Market Split by Product Type

Figure Global Gene Therapy in Oncology Revenue Market Share by Types in 2018

Figure Ex Vivo Picture

Figure In Vivo Picture

Table Global Gene Therapy in Oncology Revenue (Million USD) by Application (2014-2024)

Figure Gene Therapy in Oncology Revenue Market Share by Applications in 2018

Figure Hospitals Picture

Figure Diagnostics Centers Picture

Figure Research Institutes Picture

Table Global Market Gene Therapy in Oncology Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)

Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors

Table Bristol-Myers Squibb Gene Therapy in Oncology Type and Applications

Table Bristol-Myers Squibb Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Cold Genesys Basic Information, Manufacturing Base and Competitors

Table Cold Genesys Gene Therapy in Oncology Type and Applications

Table Cold Genesys Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Advantagene Basic Information, Manufacturing Base and Competitors

Table Advantagene Gene Therapy in Oncology Type and Applications

Table Advantagene Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Gene Therapy in Oncology Type and Applications

Table Amgen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Gene Therapy in Oncology Type and Applications

Table AstraZeneca Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Bio-Path Holdings Basic Information, Manufacturing Base and Competitors

Table Bio-Path Holdings Gene Therapy in Oncology Type and Applications

Table Bio-Path Holdings Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors

Table CRISPR Therapeutics Gene Therapy in Oncology Type and Applications

Table CRISPR Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Editas Medicine Basic Information, Manufacturing Base and Competitors

Table Editas Medicine Gene Therapy in Oncology Type and Applications

Table Editas Medicine Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Geron Corp Basic Information, Manufacturing Base and Competitors

Table Geron Corp Gene Therapy in Oncology Type and Applications

Table Geron Corp Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Idera Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Idera Pharmaceuticals Gene Therapy in Oncology Type and Applications

Table Idera Pharmaceuticals Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Intellia Therapeutics Basic Information, Manufacturing Base and Competitors

Table Intellia Therapeutics Gene Therapy in Oncology Type and Applications

Table Intellia Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Gene Therapy in Oncology Type and Applications

Table Johnson & Johnson Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Marsala Biotech Basic Information, Manufacturing Base and Competitors

Table Marsala Biotech Gene Therapy in Oncology Type and Applications

Table Marsala Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Gene Therapy in Oncology Type and Applications

Table Merck Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Mologen AG Basic Information, Manufacturing Base and Competitors

Table Mologen AG Gene Therapy in Oncology Type and Applications

Table Mologen AG Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Oncolytics Biotech Basic Information, Manufacturing Base and Competitors

Table Oncolytics Biotech Gene Therapy in Oncology Type and Applications

Table Oncolytics Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Oncosec Basic Information, Manufacturing Base and Competitors

Table Oncosec Gene Therapy in Oncology Type and Applications

Table Oncosec Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Oncotelic Basic Information, Manufacturing Base and Competitors

Table Oncotelic Gene Therapy in Oncology Type and Applications

Table Oncotelic Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Shenzhen SiBiono GeneTech Basic Information, Manufacturing Base and Competitors

Table Shenzhen SiBiono GeneTech Gene Therapy in Oncology Type and Applications

Table Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Sillajen Biotherapeutics Basic Information, Manufacturing Base and Competitors

Table Sillajen Biotherapeutics Gene Therapy in Oncology Type and Applications

Table Sillajen Biotherapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Tocagen Basic Information, Manufacturing Base and Competitors

Table Tocagen Gene Therapy in Oncology Type and Applications

Table Tocagen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table UniQure Basic Information, Manufacturing Base and Competitors

Table UniQure Gene Therapy in Oncology Type and Applications

Table UniQure Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Ziopharm Oncology Basic Information, Manufacturing Base and Competitors

Table Ziopharm Oncology Gene Therapy in Oncology Type and Applications

Table Ziopharm Oncology Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Global Gene Therapy in Oncology Revenue (Million USD) by Players (2014-2019)

Table Global Gene Therapy in Oncology Revenue Share by Players (2014-2019)

Figure Global Gene Therapy in Oncology Revenue Share by Players in 2017

Figure Global Gene Therapy in Oncology Revenue Share by Players in 2018

Figure Global Top 5 Players Gene Therapy in Oncology Revenue Market Share in 2018

Figure Global Top 10 Players Gene Therapy in Oncology Revenue Market Share in 2018

Figure Global Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Gene Therapy in Oncology Revenue (Million USD) by Regions (2014-2019)

Table Global Gene Therapy in Oncology Revenue Market Share by Regions (2014-2019)

Figure Global Gene Therapy in Oncology Revenue Market Share by Regions (2014-2019)

Figure Global Gene Therapy in Oncology Revenue Market Share by Regions in 2018

Figure North America Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Europe Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure South America Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Table North America Gene Therapy in Oncology Revenue by Countries (2014-2019)

Table North America Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)

Figure North America Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)

Figure North America Gene Therapy in Oncology Revenue Market Share by Countries in 2018

Figure USA Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Canada Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Mexico Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Table Europe Gene Therapy in Oncology Revenue (Million USD) by Countries (2014-2019)

Figure Europe Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)

Figure Europe Gene Therapy in Oncology Revenue Market Share by Countries in 2018

Figure Germany Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure UK Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure France Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Russia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Italy Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Gene Therapy in Oncology Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Gene Therapy in Oncology Revenue Market Share by Countries in 2018

Figure China Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Japan Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Korea Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure India Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Table South America Gene Therapy in Oncology Revenue by Countries (2014-2019)

Table South America Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)

Figure South America Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)

Figure South America Gene Therapy in Oncology Revenue Market Share by Countries in 2018

Figure Brazil Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Argentina Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Colombia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Gene Therapy in Oncology Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Gene Therapy in Oncology Revenue Market Share by Countries in 2018

Figure Saudi Arabia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure UAE Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Egypt Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Nigeria Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure South Africa Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Table Global Gene Therapy in Oncology Revenue (Million USD) by Type (2014-2019)

Table Global Gene Therapy in Oncology Revenue Share by Type (2014-2019)

Figure Global Gene Therapy in Oncology Revenue Share by Type (2014-2019)

Figure Global Gene Therapy in Oncology Revenue Share by Type in 2019

Table Global Gene Therapy in Oncology Revenue Forecast by Type (2019-2024)

Figure Global Gene Therapy in Oncology Market Share Forecast by Type (2019-2024)

Figure Global Ex Vivo Revenue Growth Rate (2014-2019)

Figure Global In Vivo Revenue Growth Rate (2014-2019)

Table Global Gene Therapy in Oncology Revenue by Application (2014-2019)

Table Global Gene Therapy in Oncology Revenue Share by Application (2014-2019)

Figure Global Gene Therapy in Oncology Revenue Share by Application (2014-2019)

Figure Global Gene Therapy in Oncology Revenue Share by Application in 2019

Table Global Gene Therapy in Oncology Revenue Forecast by Application (2019-2024)

Figure Global Gene Therapy in Oncology Market Share Forecast by Application (2019-2024)

Figure Global Hospitals Revenue Growth Rate (2014-2019)

Figure Global Diagnostics Centers Revenue Growth Rate (2014-2019)

Figure Global Research Institutes Revenue Growth Rate (2014-2019)

Figure Global Gene Therapy in Oncology Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Gene Therapy in Oncology Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Gene Therapy in Oncology Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

Figure Europe Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

Figure South America Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Bristol-Myers Squibb

Cold Genesys

Advantagene

Amgen

AstraZeneca

Bio-Path Holdings

CRISPR Therapeutics

Editas Medicine

Geron Corp

Idera Pharmaceuticals

Intellia Therapeutics

Johnson & Johnson

Marsala Biotech

Merck

Mologen AG

Oncolytics Biotech

Oncosec

Oncotelic

Shenzhen SiBiono GeneTech

Sillajen Biotherapeutics

Tocagen

UniQure

Ziopharm Oncology

Company Profile

Company Profile Title

Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient.

Scope of the Report:

The global Gene Therapy in Oncology market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gene Therapy in Oncology.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Gene Therapy in Oncology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gene Therapy in Oncology market by product type and applications/end industries.

Market Segment by Companies, this report covers

Bristol-Myers Squibb

Cold Genesys

Advantagene

Amgen

AstraZeneca

Bio-Path Holdings

CRISPR Therapeutics

Editas Medicine

Geron Corp

Idera Pharmaceuticals

Intellia Therapeutics

Johnson & Johnson

Marsala Biotech

Merck

Mologen AG

Oncolytics Biotech

Oncosec

Oncotelic

Shenzhen SiBiono GeneTech

Sillajen Biotherapeutics

Tocagen

UniQure

Ziopharm Oncology

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Ex Vivo

In Vivo

Market Segment by Applications, can be divided into

Hospitals

Diagnostics Centers

Research Institutes

READ MORE

Scope

Table of Contents

1 Gene Therapy in Oncology Market Overview

1.1 Product Overview and Scope of Gene Therapy in Oncology

1.2 Classification of Gene Therapy in Oncology by Types

1.2.1 Global Gene Therapy in Oncology Revenue Comparison by Types (2019-2024)

1.2.2 Global Gene Therapy in Oncology Revenue Market Share by Types in 2018

1.2.3 Ex Vivo

1.2.4 In Vivo

1.3 Global Gene Therapy in Oncology Market by Application

1.3.1 Global Gene Therapy in Oncology Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Hospitals

1.3.3 Diagnostics Centers

1.3.4 Research Institutes

1.4 Global Gene Therapy in Oncology Market by Regions

1.4.1 Global Gene Therapy in Oncology Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Gene Therapy in Oncology Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Gene Therapy in Oncology Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gene Therapy in Oncology Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Gene Therapy in Oncology Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gene Therapy in Oncology Status and Prospect (2014-2024)

1.5 Global Market Size of Gene Therapy in Oncology (2014-2024)

2 Manufacturers Profiles

2.1 Bristol-Myers Squibb

2.1.1 Business Overview

2.1.2 Gene Therapy in Oncology Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.2 Cold Genesys

2.2.1 Business Overview

2.2.2 Gene Therapy in Oncology Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Cold Genesys Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.3 Advantagene

2.3.1 Business Overview

2.3.2 Gene Therapy in Oncology Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Advantagene Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.4 Amgen

2.4.1 Business Overview

2.4.2 Gene Therapy in Oncology Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Amgen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.5 AstraZeneca

2.5.1 Business Overview

2.5.2 Gene Therapy in Oncology Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 AstraZeneca Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.6 Bio-Path Holdings

2.6.1 Business Overview

2.6.2 Gene Therapy in Oncology Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Bio-Path Holdings Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.7 CRISPR Therapeutics

2.7.1 Business Overview

2.7.2 Gene Therapy in Oncology Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 CRISPR Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.8 Editas Medicine

2.8.1 Business Overview

2.8.2 Gene Therapy in Oncology Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Editas Medicine Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.9 Geron Corp

2.9.1 Business Overview

2.9.2 Gene Therapy in Oncology Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Geron Corp Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.10 Idera Pharmaceuticals

2.10.1 Business Overview

2.10.2 Gene Therapy in Oncology Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.11 Intellia Therapeutics

2.11.1 Business Overview

2.11.2 Gene Therapy in Oncology Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Intellia Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.12 Johnson & Johnson

2.12.1 Business Overview

2.12.2 Gene Therapy in Oncology Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Johnson & Johnson Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.13 Marsala Biotech

2.13.1 Business Overview

2.13.2 Gene Therapy in Oncology Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Marsala Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.14 Merck

2.14.1 Business Overview

2.14.2 Gene Therapy in Oncology Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Merck Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.15 Mologen AG

2.15.1 Business Overview

2.15.2 Gene Therapy in Oncology Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Mologen AG Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.16 Oncolytics Biotech

2.16.1 Business Overview

2.16.2 Gene Therapy in Oncology Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Oncolytics Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.17 Oncosec

2.17.1 Business Overview

2.17.2 Gene Therapy in Oncology Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Oncosec Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.18 Oncotelic

2.18.1 Business Overview

2.18.2 Gene Therapy in Oncology Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 Oncotelic Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.19 Shenzhen SiBiono GeneTech

2.19.1 Business Overview

2.19.2 Gene Therapy in Oncology Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.20 Sillajen Biotherapeutics

2.20.1 Business Overview

2.20.2 Gene Therapy in Oncology Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 Sillajen Biotherapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.21 Tocagen

2.21.1 Business Overview

2.2.2 Gene Therapy in Oncology Type and Applications

2.21.2.1 Product A

2.21.2.2 Product B

2.21.3 Tocagen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.22 UniQure

2.22.1 Business Overview

2.22.2 Gene Therapy in Oncology Type and Applications

2.22.2.1 Product A

2.22.2.2 Product B

2.22.3 UniQure Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

2.23 Ziopharm Oncology

2.23.1 Business Overview

2.23.2 Gene Therapy in Oncology Type and Applications

2.23.2.1 Product A

2.23.2.2 Product B

2.23.3 Ziopharm Oncology Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

3 Global Gene Therapy in Oncology Market Competition, by Players

3.1 Global Gene Therapy in Oncology Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Gene Therapy in Oncology Players Market Share

3.2.2 Top 10 Gene Therapy in Oncology Players Market Share

3.3 Market Competition Trend

4 Global Gene Therapy in Oncology Market Size by Regions

4.1 Global Gene Therapy in Oncology Revenue and Market Share by Regions

4.2 North America Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

4.3 Europe Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

4.5 South America Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

5 North America Gene Therapy in Oncology Revenue by Countries

5.1 North America Gene Therapy in Oncology Revenue by Countries (2014-2019)

5.2 USA Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

5.3 Canada Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

5.4 Mexico Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

6 Europe Gene Therapy in Oncology Revenue by Countries

6.1 Europe Gene Therapy in Oncology Revenue by Countries (2014-2019)

6.2 Germany Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

6.3 UK Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

6.4 France Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

6.5 Russia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

6.6 Italy Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Gene Therapy in Oncology Revenue by Countries

7.1 Asia-Pacific Gene Therapy in Oncology Revenue by Countries (2014-2019)

7.2 China Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

7.3 Japan Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

7.4 Korea Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

7.5 India Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

8 South America Gene Therapy in Oncology Revenue by Countries

8.1 South America Gene Therapy in Oncology Revenue by Countries (2014-2019)

8.2 Brazil Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

8.3 Argentina Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

8.4 Colombia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Gene Therapy in Oncology by Countries

9.1 Middle East and Africa Gene Therapy in Oncology Revenue by Countries (2014-2019)

9.2 Saudi Arabia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

9.3 UAE Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

9.4 Egypt Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

9.5 Nigeria Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

9.6 South Africa Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

10 Global Gene Therapy in Oncology Market Segment by Type

10.1 Global Gene Therapy in Oncology Revenue and Market Share by Type (2014-2019)

10.2 Global Gene Therapy in Oncology Market Forecast by Type (2019-2024)

10.3 Ex Vivo Revenue Growth Rate (2014-2024)

10.4 In Vivo Revenue Growth Rate (2014-2024)

11 Global Gene Therapy in Oncology Market Segment by Application

11.1 Global Gene Therapy in Oncology Revenue Market Share by Application (2014-2019)

11.2 Gene Therapy in Oncology Market Forecast by Application (2019-2024)

11.3 Hospitals Revenue Growth (2014-2019)

11.4 Diagnostics Centers Revenue Growth (2014-2019)

11.5 Research Institutes Revenue Growth (2014-2019)

12 Global Gene Therapy in Oncology Market Size Forecast (2019-2024)

12.1 Global Gene Therapy in Oncology Market Size Forecast (2019-2024)

12.2 Global Gene Therapy in Oncology Market Forecast by Regions (2019-2024)

12.3 North America Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

12.4 Europe Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

12.6 South America Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Gene Therapy in Oncology Picture

Table Product Specifications of Gene Therapy in Oncology

Table Global Gene Therapy in Oncology and Revenue (Million USD) Market Split by Product Type

Figure Global Gene Therapy in Oncology Revenue Market Share by Types in 2018

Figure Ex Vivo Picture

Figure In Vivo Picture

Table Global Gene Therapy in Oncology Revenue (Million USD) by Application (2014-2024)

Figure Gene Therapy in Oncology Revenue Market Share by Applications in 2018

Figure Hospitals Picture

Figure Diagnostics Centers Picture

Figure Research Institutes Picture

Table Global Market Gene Therapy in Oncology Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (2014-2024)

Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors

Table Bristol-Myers Squibb Gene Therapy in Oncology Type and Applications

Table Bristol-Myers Squibb Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Cold Genesys Basic Information, Manufacturing Base and Competitors

Table Cold Genesys Gene Therapy in Oncology Type and Applications

Table Cold Genesys Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Advantagene Basic Information, Manufacturing Base and Competitors

Table Advantagene Gene Therapy in Oncology Type and Applications

Table Advantagene Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Amgen Basic Information, Manufacturing Base and Competitors

Table Amgen Gene Therapy in Oncology Type and Applications

Table Amgen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Gene Therapy in Oncology Type and Applications

Table AstraZeneca Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Bio-Path Holdings Basic Information, Manufacturing Base and Competitors

Table Bio-Path Holdings Gene Therapy in Oncology Type and Applications

Table Bio-Path Holdings Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors

Table CRISPR Therapeutics Gene Therapy in Oncology Type and Applications

Table CRISPR Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Editas Medicine Basic Information, Manufacturing Base and Competitors

Table Editas Medicine Gene Therapy in Oncology Type and Applications

Table Editas Medicine Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Geron Corp Basic Information, Manufacturing Base and Competitors

Table Geron Corp Gene Therapy in Oncology Type and Applications

Table Geron Corp Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Idera Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Idera Pharmaceuticals Gene Therapy in Oncology Type and Applications

Table Idera Pharmaceuticals Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Intellia Therapeutics Basic Information, Manufacturing Base and Competitors

Table Intellia Therapeutics Gene Therapy in Oncology Type and Applications

Table Intellia Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Gene Therapy in Oncology Type and Applications

Table Johnson & Johnson Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Marsala Biotech Basic Information, Manufacturing Base and Competitors

Table Marsala Biotech Gene Therapy in Oncology Type and Applications

Table Marsala Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Gene Therapy in Oncology Type and Applications

Table Merck Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Mologen AG Basic Information, Manufacturing Base and Competitors

Table Mologen AG Gene Therapy in Oncology Type and Applications

Table Mologen AG Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Oncolytics Biotech Basic Information, Manufacturing Base and Competitors

Table Oncolytics Biotech Gene Therapy in Oncology Type and Applications

Table Oncolytics Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Oncosec Basic Information, Manufacturing Base and Competitors

Table Oncosec Gene Therapy in Oncology Type and Applications

Table Oncosec Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Oncotelic Basic Information, Manufacturing Base and Competitors

Table Oncotelic Gene Therapy in Oncology Type and Applications

Table Oncotelic Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Shenzhen SiBiono GeneTech Basic Information, Manufacturing Base and Competitors

Table Shenzhen SiBiono GeneTech Gene Therapy in Oncology Type and Applications

Table Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Sillajen Biotherapeutics Basic Information, Manufacturing Base and Competitors

Table Sillajen Biotherapeutics Gene Therapy in Oncology Type and Applications

Table Sillajen Biotherapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Tocagen Basic Information, Manufacturing Base and Competitors

Table Tocagen Gene Therapy in Oncology Type and Applications

Table Tocagen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table UniQure Basic Information, Manufacturing Base and Competitors

Table UniQure Gene Therapy in Oncology Type and Applications

Table UniQure Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Ziopharm Oncology Basic Information, Manufacturing Base and Competitors

Table Ziopharm Oncology Gene Therapy in Oncology Type and Applications

Table Ziopharm Oncology Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2017-2018)

Table Global Gene Therapy in Oncology Revenue (Million USD) by Players (2014-2019)

Table Global Gene Therapy in Oncology Revenue Share by Players (2014-2019)

Figure Global Gene Therapy in Oncology Revenue Share by Players in 2017

Figure Global Gene Therapy in Oncology Revenue Share by Players in 2018

Figure Global Top 5 Players Gene Therapy in Oncology Revenue Market Share in 2018

Figure Global Top 10 Players Gene Therapy in Oncology Revenue Market Share in 2018

Figure Global Gene Therapy in Oncology Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Gene Therapy in Oncology Revenue (Million USD) by Regions (2014-2019)

Table Global Gene Therapy in Oncology Revenue Market Share by Regions (2014-2019)

Figure Global Gene Therapy in Oncology Revenue Market Share by Regions (2014-2019)

Figure Global Gene Therapy in Oncology Revenue Market Share by Regions in 2018

Figure North America Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Europe Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure South America Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Table North America Gene Therapy in Oncology Revenue by Countries (2014-2019)

Table North America Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)

Figure North America Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)

Figure North America Gene Therapy in Oncology Revenue Market Share by Countries in 2018

Figure USA Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Canada Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Mexico Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Table Europe Gene Therapy in Oncology Revenue (Million USD) by Countries (2014-2019)

Figure Europe Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)

Figure Europe Gene Therapy in Oncology Revenue Market Share by Countries in 2018

Figure Germany Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure UK Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure France Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Russia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Italy Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Gene Therapy in Oncology Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Gene Therapy in Oncology Revenue Market Share by Countries in 2018

Figure China Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Japan Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Korea Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure India Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Table South America Gene Therapy in Oncology Revenue by Countries (2014-2019)

Table South America Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)

Figure South America Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)

Figure South America Gene Therapy in Oncology Revenue Market Share by Countries in 2018

Figure Brazil Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Argentina Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Colombia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Gene Therapy in Oncology Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Gene Therapy in Oncology Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Gene Therapy in Oncology Revenue Market Share by Countries in 2018

Figure Saudi Arabia Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure UAE Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Egypt Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure Nigeria Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Figure South Africa Gene Therapy in Oncology Revenue and Growth Rate (2014-2019)

Table Global Gene Therapy in Oncology Revenue (Million USD) by Type (2014-2019)

Table Global Gene Therapy in Oncology Revenue Share by Type (2014-2019)

Figure Global Gene Therapy in Oncology Revenue Share by Type (2014-2019)

Figure Global Gene Therapy in Oncology Revenue Share by Type in 2019

Table Global Gene Therapy in Oncology Revenue Forecast by Type (2019-2024)

Figure Global Gene Therapy in Oncology Market Share Forecast by Type (2019-2024)

Figure Global Ex Vivo Revenue Growth Rate (2014-2019)

Figure Global In Vivo Revenue Growth Rate (2014-2019)

Table Global Gene Therapy in Oncology Revenue by Application (2014-2019)

Table Global Gene Therapy in Oncology Revenue Share by Application (2014-2019)

Figure Global Gene Therapy in Oncology Revenue Share by Application (2014-2019)

Figure Global Gene Therapy in Oncology Revenue Share by Application in 2019

Table Global Gene Therapy in Oncology Revenue Forecast by Application (2019-2024)

Figure Global Gene Therapy in Oncology Market Share Forecast by Application (2019-2024)

Figure Global Hospitals Revenue Growth Rate (2014-2019)

Figure Global Diagnostics Centers Revenue Growth Rate (2014-2019)

Figure Global Research Institutes Revenue Growth Rate (2014-2019)

Figure Global Gene Therapy in Oncology Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Gene Therapy in Oncology Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Gene Therapy in Oncology Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

Figure Europe Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

Figure South America Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Gene Therapy in Oncology Revenue Market Forecast (2019-2024)

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Bristol-Myers Squibb

Cold Genesys

Advantagene

Amgen

AstraZeneca

Bio-Path Holdings

CRISPR Therapeutics

Editas Medicine

Geron Corp

Idera Pharmaceuticals

Intellia Therapeutics

Johnson & Johnson

Marsala Biotech

Merck

Mologen AG

Oncolytics Biotech

Oncosec

Oncotelic

Shenzhen SiBiono GeneTech

Sillajen Biotherapeutics

Tocagen

UniQure

Ziopharm Oncology